Status:
COMPLETED
Study on the Psychotherapeutic Treatment of Chronic Nightmares
Lead Sponsor:
Goethe University
Conditions:
Nightmare Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether a change in the content of nightmares is necessary at all in the treatment of chronic nightmares or if a single confrontation with their content is su...
Detailed Description
The inclusion and exclusion criteria are assessed during a telephone interview. If the participants meet the criteria, they are randomly assigned to two intervention groups or an active control group....
Eligibility Criteria
Inclusion
- nightmare frequency of at least one night per week for six month duration
- stable medication
- if currently in psychotherapy: no treatment of nightmares
- Informed consent
Exclusion
- Life time clinical diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder according to DSM-IV
- Body mass index \< 17
- Initiation of nightmares after taking pharmaceuticals
- Clinical diagnosis of alcohol or drug addiction according to DSM-IV
- Mental retardation
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 8 2017
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT00977340
Start Date
October 1 2009
End Date
November 8 2017
Last Update
August 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johann Wolfgang Goethe University - Department of Clinical Psychology and Ppsychotherapy
Frankfurt am Main, Hesse, Germany, D-60054